ICD 10 CM E10.3211 | Description & Clinical Information

ICD 10 E10.3211 describes a medical condition known as Type 1 diabetes mellitus (DM type 1) with mild nonproliferative diabetic retinopathy (NPDR), which is a chronic autoimmune disease that results from the destruction of pancreatic beta cells, leading to insufficient insulin production and high blood glucose levels that gradually damage the blood supply to the retina, causing minimal growth of new blood vessels and macular edema, characterized by the accumulation of fluid in the macula, and this code is used to report cases of DM type 1 with mild NPDR and macular edema in the right eye.

Official Description Of E10.3211

The ICD 10 CM book defines ICD 10 code E10.3211 as:

Clinical Information

The diagnosis describes by the code ICD 10 CM E10.3211 is a medical condition known as Nonproliferative Diabetic Retinopathy (NPDR). This condition is characterized by the presence of lesions in the retina, including small dot or blot hemorrhages, microaneurysms, splinter hemorrhages, and intraretinal microvascular abnormalities. The severity of these lesions determines if the NPDR is mild, moderate, or severe.

In mild NPDR cases, at least one dot hemorrhage and one microaneurysm can be found in all four quadrants of the fundus. The fundus is the part of the eye opposite the lens and includes the retina. The macula, located in the center of the retina, is responsible for the perception of the sharpest vision.

Macular edema occurs when fluid accumulates in the macula, resulting from the leakage of blood vessels in the retina. Patients with DM type 1 who suffer from mild NPDR with macular edema of the right eye may experience various symptoms such as cotton wool spots, swelling of the macula, blurred vision, light flashes, dark spots and rings, pain and pressure in the eyes, poor vision, and if untreated, vision loss. In addition, they can experience other symptoms such as dizziness, fatigue, nausea, excessive thirst (polydipsia), frequent urination (polyuria), increased hunger (polyphagia), and unintentional weight loss.

Providers diagnose NPDR based on the medical history, physical examination results, and signs and symptoms displayed by the patient. Diagnostic eye tests may be performed such as ophthalmoscopy, tonometry, fundus photography, optical coherence tomography, fluorescein or indocyanine green angiography, and Bscan ultrasonography. Diagnostic tests for DM type 1 can include glucose tolerance tests, plasma glucose levels, HbA1c levels, CBC, urine for albumin, glucose, and ketones, and antiinsulin antibodies.

Treatment for NPDR with macular edema of the right eye may include laser photocoagulation to treat leaking blood vessels, vitrectomy, and anti-VEGF or steroid injections. Treatment for DM type 1 involves lifelong insulin therapy, diet management, and blood glucose monitoring. Patients with DM type 1 must regularly monitor their blood sugar levels using fingerstick monitors or continuous glucose monitoring devices that measure interstitial blood glucose for patients whose disease is difficult to manage. Insulin pumps may be required to manage the condition for some patients.

In conclusion, NPDR with macular edema of the right eye is a medical condition that requires careful management and treatment. By having the required diagnostic tests and receiving the appropriate treatment, patients can improve their symptoms and maintain their quality of life. It is essential that patients with DM type 1 adhere to their treatment plan and monitoring devices to prevent further complications. Medical coders play a vital role in ensuring that healthcare providers receive accurate and timely reimbursement for services rendered to patients diagnosed with NPDR and DM type 1.